| UniProt ID | PMYT1_HUMAN | |
|---|---|---|
| UniProt AC | Q99640 | |
| Protein Name | Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | |
| Gene Name | PKMYT1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 499 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Peripheral membrane protein . Golgi apparatus membrane Peripheral membrane protein . |
|
| Protein Description | Acts as a negative regulator of entry into mitosis (G2 to M transition) by phosphorylation of the CDK1 kinase specifically when CDK1 is complexed to cyclins. Mediates phosphorylation of CDK1 predominantly on 'Thr-14'. Also involved in Golgi fragmentation. May be involved in phosphorylation of CDK1 on 'Tyr-15' to a lesser degree, however tyrosine kinase activity is unclear and may be indirect. May be a downstream target of Notch signaling pathway during eye development.. | |
| Protein Sequence | MLERPPALAMPMPTEGTPPPLSGTPIPVPAYFRHAEPGFSLKRPRGLSRSLPPPPPAKGSIPISRLFPPRTPGWHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQPRAWGVLWCMAAEALSRGWALWQALLALLCWLWHGLAHPASWLQPLGPPATPPGSPPCSLLLDSSLSSNWDDDSLGPSLSPEAVLARTVGSTSTPRSRCTPRDALDLSDINSEPPRGSFPSFEPRNLLSLFEDTLDPT | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MLERPPAL -------CCCCCCCC | 8.71 | 20068231 | |
| 14 | Phosphorylation | ALAMPMPTEGTPPPL CCCCCCCCCCCCCCC | 40.57 | 22199227 | |
| 17 | Phosphorylation | MPMPTEGTPPPLSGT CCCCCCCCCCCCCCC | 26.79 | 25159151 | |
| 22 | Phosphorylation | EGTPPPLSGTPIPVP CCCCCCCCCCCCCCC | 46.52 | 22199227 | |
| 24 | Phosphorylation | TPPPLSGTPIPVPAY CCCCCCCCCCCCCCC | 18.05 | 22199227 | |
| 31 | Phosphorylation | TPIPVPAYFRHAEPG CCCCCCCCCCCCCCC | 8.62 | 27273156 | |
| 40 | Phosphorylation | RHAEPGFSLKRPRGL CCCCCCCCCCCCCCC | 38.61 | 30266825 | |
| 42 | Methylation | AEPGFSLKRPRGLSR CCCCCCCCCCCCCCC | 60.19 | 82981881 | |
| 42 | Ubiquitination | AEPGFSLKRPRGLSR CCCCCCCCCCCCCCC | 60.19 | - | |
| 48 | Phosphorylation | LKRPRGLSRSLPPPP CCCCCCCCCCCCCCC | 23.73 | 20068231 | |
| 50 | Phosphorylation | RPRGLSRSLPPPPPA CCCCCCCCCCCCCCC | 41.68 | 30266825 | |
| 58 | Ubiquitination | LPPPPPAKGSIPISR CCCCCCCCCCCCHHH | 59.99 | - | |
| 60 | Phosphorylation | PPPPAKGSIPISRLF CCCCCCCCCCHHHCC | 25.20 | 20068231 | |
| 64 | Phosphorylation | AKGSIPISRLFPPRT CCCCCCHHHCCCCCC | 19.99 | 20068231 | |
| 71 | Phosphorylation | SRLFPPRTPGWHQLQ HHCCCCCCCCCCCCC | 31.74 | 23312004 | |
| 89 | Phosphorylation | VSFRGEASETLQSPG EEECCCHHHHHCCCC | 27.15 | 30266825 | |
| 91 | Phosphorylation | FRGEASETLQSPGYD ECCCHHHHHCCCCCC | 27.83 | 30266825 | |
| 94 | Phosphorylation | EASETLQSPGYDPSR CHHHHHCCCCCCCCC | 24.33 | 30266825 | |
| 97 | Phosphorylation | ETLQSPGYDPSRPES HHHCCCCCCCCCCHH | 28.23 | 30266825 | |
| 100 | Phosphorylation | QSPGYDPSRPESFFQ CCCCCCCCCCHHHHH | 58.53 | 30266825 | |
| 104 | Phosphorylation | YDPSRPESFFQQSFQ CCCCCCHHHHHHHHH | 33.76 | 30266825 | |
| 109 | Phosphorylation | PESFFQQSFQRLSRL CHHHHHHHHHHHHCC | 16.74 | 26055452 | |
| 120 | Phosphorylation | LSRLGHGSYGEVFKV HHCCCCCCCCCEEEE | 25.04 | 25159151 | |
| 121 | Phosphorylation | SRLGHGSYGEVFKVR HCCCCCCCCCEEEEE | 23.15 | 28796482 | |
| 126 | Ubiquitination | GSYGEVFKVRSKEDG CCCCCEEEEEECCCC | 41.75 | 21906983 | |
| 126 | Methylation | GSYGEVFKVRSKEDG CCCCCEEEEEECCCC | 41.75 | 42359113 | |
| 136 | Phosphorylation | SKEDGRLYAVKRSMS ECCCCCEEEEEECCC | 14.16 | 20068231 | |
| 139 | Ubiquitination | DGRLYAVKRSMSPFR CCCEEEEEECCCCCC | 30.50 | - | |
| 141 | Phosphorylation | RLYAVKRSMSPFRGP CEEEEEECCCCCCCH | 20.21 | 30266825 | |
| 143 | Phosphorylation | YAVKRSMSPFRGPKD EEEEECCCCCCCHHH | 23.33 | 25159151 | |
| 149 | Ubiquitination | MSPFRGPKDRARKLA CCCCCCHHHHHHHHH | 63.77 | - | |
| 154 | Ubiquitination | GPKDRARKLAEVGSH CHHHHHHHHHHHCCC | 51.57 | 21906983 | |
| 160 | Phosphorylation | RKLAEVGSHEKVGQH HHHHHHCCCCCCCCC | 33.38 | 25159151 | |
| 163 | Ubiquitination | AEVGSHEKVGQHPCC HHHCCCCCCCCCCCE | 46.36 | - | |
| 330 | Phosphorylation | EFTAGLSSELRSVLV HHHCCCCHHHHHHHH | 45.77 | 24719451 | |
| 345 | Ubiquitination | MMLEPDPKLRATAEA HHHCCCHHHHHHHHH | 58.97 | - | |
| 412 | Phosphorylation | QPLGPPATPPGSPPC CCCCCCCCCCCCCCC | 35.47 | 26074081 | |
| 416 | Phosphorylation | PPATPPGSPPCSLLL CCCCCCCCCCCCEEE | 31.29 | 26074081 | |
| 420 | Phosphorylation | PPGSPPCSLLLDSSL CCCCCCCCEEECCCC | 28.03 | 26074081 | |
| 426 | Phosphorylation | CSLLLDSSLSSNWDD CCEEECCCCCCCCCC | 31.75 | 22817900 | |
| 441 | Phosphorylation | DSLGPSLSPEAVLAR CCCCCCCCHHHHHHH | 25.65 | 22817900 | |
| 449 | Phosphorylation | PEAVLARTVGSTSTP HHHHHHHHCCCCCCC | 24.50 | 28102081 | |
| 452 | Phosphorylation | VLARTVGSTSTPRSR HHHHHCCCCCCCCCC | 18.17 | 29396449 | |
| 453 | Phosphorylation | LARTVGSTSTPRSRC HHHHCCCCCCCCCCC | 30.59 | 28985074 | |
| 454 | Phosphorylation | ARTVGSTSTPRSRCT HHHCCCCCCCCCCCC | 37.80 | 28176443 | |
| 455 | Phosphorylation | RTVGSTSTPRSRCTP HHCCCCCCCCCCCCC | 23.86 | 25849741 | |
| 458 | Phosphorylation | GSTSTPRSRCTPRDA CCCCCCCCCCCCCHH | 32.67 | 23312004 | |
| 461 | Phosphorylation | STPRSRCTPRDALDL CCCCCCCCCCHHCCH | 21.90 | 22817900 | |
| 469 | Phosphorylation | PRDALDLSDINSEPP CCHHCCHHHCCCCCC | 35.79 | 30266825 | |
| 473 | Phosphorylation | LDLSDINSEPPRGSF CCHHHCCCCCCCCCC | 52.38 | 23927012 | |
| 479 | Phosphorylation | NSEPPRGSFPSFEPR CCCCCCCCCCCCCCH | 34.95 | 23401153 | |
| 482 | Phosphorylation | PPRGSFPSFEPRNLL CCCCCCCCCCCHHHH | 39.99 | 30266825 | |
| 490 | Phosphorylation | FEPRNLLSLFEDTLD CCCHHHHHHHHHCCC | 33.89 | 29485707 | |
| 495 | Phosphorylation | LLSLFEDTLDPT--- HHHHHHHCCCCC--- | 26.34 | 12738781 | |
| 499 | Phosphorylation | FEDTLDPT------- HHHCCCCC------- | 51.41 | 20873877 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PMYT1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PMYT1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PIN1_HUMAN | PIN1 | physical | 9499405 | |
| MK08_HUMAN | MAPK8 | physical | 19204086 | |
| MK10_HUMAN | MAPK10 | physical | 19204086 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40; SER-50; SER-120;SER-469 AND SER-473, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-17; SER-94; SER-120;SER-143; SER-160; SER-469 AND THR-495, AND MASS SPECTROMETRY. | |
| "Proteomics analysis of protein kinases by target class-selectiveprefractionation and tandem mass spectrometry."; Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,Keri G., Wehland J., Daub H.; Mol. Cell. Proteomics 6:537-547(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143, AND MASSSPECTROMETRY. | |
| "Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-94, AND MASSSPECTROMETRY. | |
| "Identification of a consensus motif for Plk (Polo-like kinase)phosphorylation reveals Myt1 as a Plk1 substrate."; Nakajima H., Toyoshima-Morimoto F., Taniguchi E., Nishida E.; J. Biol. Chem. 278:25277-25280(2003). Cited for: PHOSPHORYLATION AT SER-426 AND THR-495. | |